Unique ID issued by UMIN | UMIN000001042 |
---|---|
Receipt number | R000001190 |
Scientific Title | Multi-institutional phase II study of concurrent chemoradiotherapy using high-dose-rate intracavitary brachytherapy for locally advanced uterine cervical cancer. |
Date of disclosure of the study information | 2008/02/19 |
Last modified on | 2018/08/13 13:49:59 |
Multi-institutional phase II study of concurrent chemoradiotherapy using high-dose-rate intracavitary brachytherapy for locally advanced uterine cervical cancer.
CCRT for locally advanced cervical cancer
Multi-institutional phase II study of concurrent chemoradiotherapy using high-dose-rate intracavitary brachytherapy for locally advanced uterine cervical cancer.
CCRT for locally advanced cervical cancer
Japan |
Locally advanced cervical cancer
Obstetrics and Gynecology | Radiology |
Malignancy
NO
To evaluate safety and efficacy of concurrent chemoradiotherapy with radiotherapy of Japanese standard schedule for patients with locally advanced (FIGO stage III and IVA) uterine cervical cancer.
Safety,Efficacy
Progression-free survival
Feasibility, Toxicity, Tumor response, Overall survival
Interventional
Single arm
Non-randomized
Open -no one is blinded
Active
1
Treatment
Medicine |
Concurrent chemoradiotherapy: CCRT
Cisplatin (40mg/m2, weekly, 5 courses)
Radiothrapy: BED 74-78Gy10
External beam: whole pelvis 50-50.4Gy/25-28fr (CS after 30-41.4Gy)
HDR-ICBT : 6Gy x 3-4 (point A)
20 | years-old | <= |
70 | years-old | >= |
Female
1)Pathologically confirmed cervix cancer
2)Eastern Cooperative Oncology Group (ECOG) performance status of 0 to 1
3)20 years-old<=age<=75 years-old
4)FIGO Stage3a,3b,4a
5)No prior treatments
6)Adequate bone marrow,cardiac,pulmonry function
Absolute neutrophil count:
>= 2,000/mm3
Hemoglobin: >= 10.0g/dL
Platelet count: >= 100,000/mm3
Bilirubin: <1.5mg/dL
AST/ALT: <100 IU/l
Serum creatinine: < 1.2mg/dL
creatinine clearance > 50 ml/min
ECG Normal
7)Written informed consent
1) Patients with stump cancer
2) Patients with active infections
3) Patients with hydronephrosis
4) Patients with unstable angina, history of cardiac infarction within 6 months, or arrhythmia that requires medical treatment
5) Patients with serious complications
6) Patients who previously received pelvic radiotherapy
7) Patients with active concomitant malignancy
8) Patients who have undergone surgical staging
9) Patients with psychiatric illness that would prevent informed consent
10) Patients during pregnancy or breast-feeding, or unwilling to the use of contraception
11)Patients who are inappropriate to enter this study with any safety reasons, judged by the treating physician
70
1st name | |
Middle name | |
Last name | Takafumi Toita |
University of the Ryukyus
Department of Radiology, Graduate School of Medical Science
207 Uehara, Nishinhara-cho, Okinawa, 903-0215, Japan
03-3353-1211
1st name | |
Middle name | |
Last name | Takafumi Toita |
JGOG1066 Coordinating Office
University of the Ryukyus
207 Uehara, Nishinhara-cho, Okinawa, 903-0215, Japan
03-3353-1211
http://www.jgog.gr.jp/
gog1066@jgog.gr.jp
Japanese Gynecologic Oncology Group
Japanese Gynecologic Oncology Group
Non profit foundation
NO
2008 | Year | 02 | Month | 19 | Day |
Published
https://www.ncbi.nlm.nih.gov/pubmed/21331768
Completed
2007 | Year | 12 | Month | 27 | Day |
2008 | Year | 01 | Month | 01 | Day |
2011 | Year | 02 | Month | 01 | Day |
2011 | Year | 03 | Month | 01 | Day |
2011 | Year | 04 | Month | 01 | Day |
2011 | Year | 07 | Month | 01 | Day |
2008 | Year | 02 | Month | 19 | Day |
2018 | Year | 08 | Month | 13 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000001190